General Announcement::ACROMETA receives LOA for S$6.1m design & build works from a global clinical research organisation

Issuer & Securities

Issuer/ Manager
ACROMETA GROUP LIMITED
Securities
ACROMETA GROUP LIMITED - SG1CH1000006 - 43F
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
29-Dec-2022 18:43:22
Status
New
Announcement Sub Title
ACROMETA receives LOA for S$6.1m design & build works from a global clinical research organisation
Announcement Reference
SG221229OTHRV0OD
Submitted By (Co./ Ind. Name)
Lim Say Chin
Designation
Executive Chairman and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.

Attachments

Acrometa-PressRelease $6.1m_final.pdf
Total size =650K